Diploma (LON:DPLM) Shares Pass Above 200 Day Moving Average – Should You Sell?

Diploma PLC (LON:DPLM)’s stock price crossed above its two hundred day moving average during trading on Tuesday . The stock has a two hundred day moving average of GBX 5,008.13 and traded as high as GBX 5,550. Diploma shares last traded at GBX 5,423.37, with a volume of 614,289 shares changing hands.

Wall Street Analyst Weigh In

Several analysts have issued reports on the company. JPMorgan Chase & Co. reissued a “neutral” rating and set a GBX 4,440 price target on shares of Diploma in a report on Wednesday, August 6th. Shore Capital reaffirmed a “hold” rating and issued a GBX 5,100 price objective on shares of Diploma in a research note on Thursday, July 17th. Royal Bank Of Canada raised Diploma to an “outperform” rating and upped their price objective for the stock from GBX 4,500 to GBX 6,000 in a research note on Friday, October 3rd. Jefferies Financial Group upped their price objective on Diploma from GBX 4,500 to GBX 5,200 and gave the stock a “hold” rating in a research note on Thursday, September 11th. Finally, Berenberg Bank upped their price objective on Diploma from GBX 5,750 to GBX 6,350 and gave the stock a “buy” rating in a research note on Wednesday, September 10th. Three analysts have rated the stock with a Buy rating and three have issued a Hold rating to the company. According to data from MarketBeat.com, the company currently has an average rating of “Moderate Buy” and a consensus price target of GBX 5,365.

Diploma Price Performance

The firm’s fifty day simple moving average is GBX 5,421.22 and its 200 day simple moving average is GBX 5,008.13. The firm has a market cap of £7.37 billion, a P/E ratio of 44.25, a P/E/G ratio of 2.82 and a beta of 0.75. The company has a debt-to-equity ratio of 62.17, a quick ratio of 0.80 and a current ratio of 2.17.

About Diploma

Diploma PLC, together with its subsidiaries, supplies specialized technical products and services in the United Kingdom, Continental Europe, North America, and internationally. It operates through three business sectors: Life Sciences, Seals, and Controls. The Life Sciences sector supplies technology-enabled products used in surgical procedures in operating theatres and endoscopy; testing equipment and services for clinical laboratories; and bio-pharma, food safety and testing, and other research-oriented products.